Institutional investors hold a majority ownership of ILMN through the 97.94% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK ADVISORS LLC Bought 489.0 Thousand shares of Illumina Inc